Benzinga | Feb 11, 2021 04:03PM EST

Seattle Genetics Q4 EPS $0.90 Beats $0.86 Estimate, Sales $601.29M Beat $586.57M Estimate

Seattle Genetics (NASDAQ:SGEN) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.86 by 4.65 percent. This is a 542.86 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $601.29 million which beat the analyst consensus estimate of $586.57 million by 2.51 percent. This is a 107.49 percent increase over sales of $289.80 million the same period last year.